Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
41
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

Fu-Chao Ma1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Qian Yu1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Zhi-Ming Zeng1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Rong-Quan He1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Chao-Hua Mo2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
,
Jin-Cai Zhong1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Jie Ma1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Zhen-Bo Feng2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
,
Gang Chen2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
&
Xiao-Hua Hu1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, NanningCorrespondence[email protected]
 show all
Pages 5237-5242 | Published online: 01 Nov 2017

References

  • ShaibYEl-SeragHBThe epidemiology of cholangiocarcinomaSemin Liver Dis200424211512515192785
  • FargesOFuksDBoleslawskiEInfluence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study groupAnn Surg2011254582483022042474
  • MechteldCde JongNathanHariIntrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessmentJ Clin Oncol201129233140314521730269
  • LiJinQinShukuiXuJianmingApatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJ Clin Oncol201331263219322523918952
  • LiJQinSXuJRandomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctionJ Clin Oncol201634131448145426884585
  • QinSApatinib in Chinese patients with advanced hepatocellular carcinoma: a phase II randomized, open-label trialJ Clin Oncol201432Suppl 5 abstract 4019
  • HuXZhangJXuBMulticenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancerInt J Cancer201413581961196924604288
  • ScottAJMessersmithWAJimenoAApatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumorsDrugs Today (Barc)201551422322926020064
  • FontanellaCOngaroEBolzonelloSClinical advances in the development of novel VEGFR2 inhibitorsAnn Transl Med201421212325568876
  • DohertyBNambudiriVEPalmerWCUpdate on the diagnosis and treatment of cholangiocarcinomaCurr Gastroenterol Rep2017191228110453
  • CunninghamSCChotiMABellavanceECPawlikTMPalliation of hepatic tumorsSurg Oncol200716427729117935975
  • LimKHHanSWOhDYImSAKimTYBangYJOutcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancerOncology2012832576622760079
  • ValleJWasanHPalmerDHCisplatin plus gemcitabine versus gemcitabine for biliary tract cancerN Engl J Med2010362141273128120375404
  • PengHZhangQLiJApatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinomaOncotarget2016713172201722926967384
  • FerraraNVascular endothelial growth factor as a target for anticancer therapyOncologist20049Suppl 121015178810
  • FerraraNGerberHPLeCouterJThe biology of VEGF and its receptorsNat Med20039666967612778165
  • Glade-BenderJKandelJJYamashiroDJVEGF blocking therapy in the treatment of cancerExpert Opin Biol Ther20033226327612662141
  • ScottAJMessersmithWAJimenoAApatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumorsDrugs Today (Barc)201551422322926020064
  • LiJZhaoXChenLSafety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignanciesBMC Cancer20101052920923544
  • LiJQinSXuJApatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJ Clin Oncol201331263219322523918952
  • HuXCaoJHuWMulticenter phase II study of apatinib in non-triple-negative metastatic breast cancerBMC Cancer20141482025376790
  • LangerCJMokTPostmusPETargeted agents in the third/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)Cancer Treat Rev201339325226022703830
  • SangHLiTLiHLiuJGab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinomaTumor Biol2015361183678377

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.